Saeed Motahari

58 year

Health Technology

Consumer Services

Profile

Saeed Motahari served as the President, Chief Executive Officer & Director at INSYS Therapeutics, Inc. from 2017 to 2019.
Prior to that, he worked as the Chief Commercial Officer at Purdue Pharma LP.
He also worked as a Principal at AbbVie, Inc. Mr. Motahari received his undergraduate and graduate degrees from Concordia University.

Former positions of Saeed Motahari

Companies	Position	End
INSYS THERAPEUTICS, INC.	Chief Executive Officer	14/04/2019
ABBVIE INC.	Corporate Officer/Principal	-
Purdue Pharma LP Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT.	Corporate Officer/Principal	-

See the detail of Saeed Motahari's experience

Training of Saeed Motahari

Concordia University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Saeed Motahari's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ABBVIE INC.	Health Technology

Private companies	2
Purdue Pharma LP Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT.	Health Technology
INSYS Therapeutics, Inc. INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ.	Health Technology